Your browser doesn't support javascript.
loading
Door-to-needle time for thrombolysis: a secondary analysis of the TIPS cluster randomised controlled trial.
Hasnain, Md Golam; Paul, Christine L; Attia, John R; Ryan, Annika; Kerr, Erin; D'Este, Catherine; Hall, Alix; Milton, Abul Hasnat; Hubbard, Isobel J; Levi, Christopher R.
Afiliação
  • Hasnain MG; School of Medicine and Public Health (SMPH), Faculty of Health and Medicine, University of Newcastle (UoN), Callaghan, New South Wales, Australia mdgolam.hasnain@uon.edu.au.
  • Paul CL; School of Medicine and Public Health (SMPH), Faculty of Health and Medicine, University of Newcastle (UoN), Callaghan, New South Wales, Australia.
  • Attia JR; School of Medicine and Public Health (SMPH), Faculty of Health and Medicine, University of Newcastle (UoN), Callaghan, New South Wales, Australia.
  • Ryan A; Hunter Medical Research Institute (HMRI), Clinical Research Design and Statistical Services, New Lambton Heights, New South Wales, Australia.
  • Kerr E; School of Medicine and Public Health (SMPH), Faculty of Health and Medicine, University of Newcastle (UoN), Callaghan, New South Wales, Australia.
  • D'Este C; John Hunter Hospital, Department of Neurology, New Lambton Heights, New South Wales, Australia.
  • Hall A; School of Medicine and Public Health (SMPH), Faculty of Health and Medicine, University of Newcastle (UoN), Callaghan, New South Wales, Australia.
  • Milton AH; National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University (ANU), Acton, Australian Capital Territory, Australia.
  • Hubbard IJ; Hunter Medical Research Institute (HMRI), Clinical Research Design and Statistical Services, New Lambton Heights, New South Wales, Australia.
  • Levi CR; Epidemiology Resource Centre, Dhaka, Dhaka, Bangladesh.
BMJ Open ; 9(12): e032482, 2019 12 15.
Article em En | MEDLINE | ID: mdl-31843839
ABSTRACT

OBJECTIVE:

The current study aimed to evaluate the effects of a multi-component in-hospital intervention on the door-to-needle time for intravenous thrombolysis in acute ischaemic stroke.

DESIGN:

This study was a post hoc analysis of door-to-needle time data from a cluster-randomised controlled trial testing an intervention to boost intravenous thrombolysis implementation.

SETTING:

The study was conducted among 20 hospitals from three Australian states. PARTICIPANT Eligible hospitals had a Stroke Care Unit or staffing equivalent to a stroke physician and a nurse, and were in the early stages of implementing thrombolysis. INTERVENTION The intervention was multifaceted and developed using the behaviour change wheel and informed by breakthrough collaborative methodology using components of the health behaviour change wheel. PRIMARY AND SECONDARY OUTCOME

MEASURES:

The primary outcome for this analysis was door-to-needle time for thrombolysis and secondary outcome was the proportion of patients received thrombolysis within 60 min of hospital arrival.

RESULTS:

The intervention versus control difference in the door-to-needle times was non-significant overall nor significant by hospital classification. To provide additional context for the findings, we also evaluated the results within intervention and control hospitals. During the active-intervention period, the intervention hospitals showed a significant decrease in the door-to-needle time of 9.25 min (95% CI -16.93 to 1.57), but during the post-intervention period, the result was not significant. During the active intervention period, control hospitals also showed a significant decrease in the door-to-needle time of 5.26 min (95% CI -8.37 to -2.14) and during the post-intervention period, this trend continued with a decrease of 12.13 min (95% CI -17.44 to 6.81).

CONCLUSION:

Across these primary stroke care centres in Australia, a secular trend towards shorter door-to-needle times across both intervention and control hospitals was evident, however the TIPS (Thrombolysis ImPlementation in Stroke) intervention showed no overall effect on door-to-needle times in the randomised comparison. TRIAL REGISTRATION NUMBER Trial Registration-URL http//www.anzctr.org.au/ Unique Identifier ACTRN 12613000939796.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Acidente Vascular Cerebral / Fibrinolíticos / Tempo para o Tratamento Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Revista: BMJ Open Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Acidente Vascular Cerebral / Fibrinolíticos / Tempo para o Tratamento Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Revista: BMJ Open Ano de publicação: 2019 Tipo de documento: Article